BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huber W, Ruiz de Garibay AP. Options in extracorporeal support of multiple organ failure. Med Klin Intensivmed Notfmed 2020;115:28-36. [PMID: 32095838 DOI: 10.1007/s00063-020-00658-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Huber W, Lorenz G, Heilmaier M, Böttcher K, Sahm P, Middelhoff M, Ritzer B, Schulz D, Bekka E, Hesse F, Poszler A, Geisler F, Spinner C, Schmid RM, Lahmer T. Extracorporeal multiorgan support including CO2-removal with the ADVanced Organ Support (ADVOS) system for COVID-19: A case report. Int J Artif Organs 2021;44:288-94. [PMID: 32985328 DOI: 10.1177/0391398820961781] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 König C, Kluge S, Fuhrmann V, Jarczak D. Pharmacokinetics of meropenem during advanced organ support (ADVOS®) and continuous renal replacement therapy. Int J Artif Organs 2021;:3913988211021101. [PMID: 34144656 DOI: 10.1177/03913988211021101] [Reference Citation Analysis]
3 Fuhrmann V, Perez Ruiz de Garibay A, Faltlhauser A, Tyczynski B, Jarczak D, Lutz J, Weinmann-Menke J, Kribben A, Kluge S. Registry on extracorporeal multiple organ support with the advanced organ support (ADVOS) system: 2-year interim analysis. Medicine (Baltimore) 2021;100:e24653. [PMID: 33607801 DOI: 10.1097/MD.0000000000024653] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]